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Background: Gene therapeutic-delivered overexpression of P-
glycoprotein (P-gp), the product of MDR1 (multidrug resistance
1) gene, might protect normal tissue during chemo- and radio-
therapy of P-gp-expressing tumors. However, little is known
about the influence of MDR1-overexpression on the expression
of other genes.
Methods: Differentially gene expression in untransduced and
oncoretrovirally transduced human lymphoblastoid TK6 cells
were analysed by using the GeneChip Human Genome U133
Plus2.0 (Affymetrix). The expression of several genes was vali-
dated with quantitative real-time PCR (TaqMan; Applied Biosys-
tems). Radiation-induced apoptosis was analysed by the sub-G1
DNA content using flow cytometry. Cell survival was measured
by the colony formation assay.
Results: Sixty-one annotated genes showed a significant change
in expression (p < 104) in MDR1-overexpressing compared to
untransduced and control virus-transduced cells. Several genes
coding for proteins involved in detoxification and exocytosis (e.g.
ALDH1A, UNC13) were up-regulated. Additionally, proapoptotic
genes were down-regulated (e.g. CASP1, CASP4) with concomitant
increased expression of the potential antiapoptotic gene AKT3. In
functional assays overexpression of MDR1 conferred protection
against radiation-induced clonogenic inactivation and apoptosis.
Conclusion: The resistant phenotype of MDR1-mediated P-gp
overexpressing cells is associated with differential expression of
several genes coding for metabolic as well as pro- and antiapopto-
tic proteins. Our results could have important implications for
MDR1-gene therapy in patients receiving chemotherapy regimens
in combination with radiotherapy.
doi:10.1016/j.ejcsup.2006.04.079
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Background: BAFF, APRIL and TNFR-family members are involved
in various cancers including B cell malignancies. The aim of thestudy is to identify new therapeutic targets in multiple myeloma
using gene expression analysis.
Methods: Samples of 65 patients (CD138-purified myeloma cells
(MMC) and bone-marrow-microenvironment (BMME)), 7 normal
bone-marrow-plasma-cell-samples (BMPC), 7 in vitro generated
osteoclast-samples, and 20 human-myeloma-cell-lines were
investigated. The expression of TACI, BCMA and BAFFR and the
respective ligands BAFF and APRIL on MMC and BMSC was
assessed by quantitative RT-PCR and Affymetrix U133 A + B
DNA-microarrays. BMMAs of MM-patients were exposed to the
TACI-Fc5 fusion-protein (Serono) containing the extracellular
BAFF/APRIL-binding domain of TACI and the Fc-region of human
Immungobulin G, to neutralize BAFF and APRIL secreted by MMC/
BMME.
Results: MMC express TACI, the receptor of BAFF/APRIL. BAFF
and APRIL promote MMC growth. The main site of production
for BAFF and APRIL is the BMME, i.e. monocytes/neutrophils and
osteoclasts, respectively.1,2 The TACI-Fc5 fusion protein is cur-
rently under investigation in a clinical phase I/II trial at the Uni-
versity Hospitals of Montpellier and Heidelberg.
Conclusion: Inhibiting TACI-signaling via BAFF and APRIL by a
TACI-Fc5 fusion protein is a promising new therapeutic approach
in the treatment of MM.
doi:10.1016/j.ejcsup.2006.04.080
P21. A MOLECULAR CLASSIFICATION OF MULTIPLE
MYELOMA (MM) BASED ON GENE EXPRESSION PROFILING AND
FLUORESCENCE IN SITU HYBRIDISATION AS INDEPENDENT
PROGNOSTIC FACTOR FOR EVENT FREE SURVIVAL (EFS)
Dirk Hosea, John De Vosb, Carina Ittrichc, Jean-Franc¸ois Rossib,e,
Thierry Re`meb, Axel Bennerc, Kare`ne Mahtoukb, Coral del Valf,
Agnes Hotz-Wagenblattf, Je´roˆme Moreauxb, Sunitha Jonnakutf,
Marc Raaba, Philine Kaukela, Marion Moosa, Veronique Graub,
Anna Jauchd, Eric Jourdanb, Friedrich W. Cremera, Bernard Kleinb,
Hartmut Goldschmidta. aMedizinische Klinik V, Heidelberg,
Germany; bINSERM U475 and CHU Montpellier, Montpellier,
France; cAbteilung fu¨r Biostatistik, DKFZ, Heidelberg,
Germany; dInstitut fu¨r Humangenetik, Heidelberg, Germany; eCellgen
SA, Montpellier, France; fAbteilung fu¨r Molekulare Biophysik, DKFZ,
Heidelberg, Germany.
Background: To test the ability of our EC-classification1,2 to (i)
predict EFS in 100 MM-patients treated with high-dose-chemo-
therapy and autologous-stem-cell-transplantation, (ii) investigate
whether the classification represents an independent prognostic
factor.
Methods: 128 newly-diagnosed MM-patients (65 training-group/
63 validation-group) were included. Bone-marrow aspirates
were CD138-purified and RNA subjected to Affymetrix HG
U133 A + B (training-group) and 2.0+ (validation-group) arrays.
CCND1-, CCND2- and FGFR3-expression were verified by RT-
PCR and Western-blotting. iFISH was performed for chromo-
somes 1q21, 11q23, 11q13, 13q14, 17p13, t(4;14) and t(11;14).
Expression data were gcrma-normalised and nearest-shrun-
ken-centroids applied to cross-validate a predictor on the train-
ing-group. Log-rank test and Cox-proportional-hazard-model
